Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TP73 alterations in cervical carcinoma.

Rogéria Craveiro1, Sandra Costa, Daniela Pinto

  • 1Department of Radiotherapy, Instituto Português de Oncologia, Porto, Rua Dr. Ant. Bernardino Almeida, 4200-072 Porto, Portugal.

Cancer Genetics and Cytogenetics
|April 7, 2004
PubMed
Summary

Human papillomaviruses (HPV) drive cervical cancer, but TP73 gene alterations, like loss of heterozygosity (LOH), are also involved. The GC/AT genotype correlated with earlier menarche and high parity, suggesting TP73

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current Features of Aortic Graft and Endograft Infections: A Single-Centre Study of 37 Patients on the Effects of Medical and Surgical Treatment.

Journal of clinical medicine·2026
Same author

Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma Registry.

The Lancet. Respiratory medicine·2026
Same author

Probiotics in football (soccer): a survey on practitioner's current perceptions and practices.

Science & medicine in football·2026
Same author

Impact of radiotherapy timing on survival and radiotoxicity outcomes in localized prostate cancer: a retrospective cohort study.

La Radiologia medica·2026
Same author

Chronotype-based radiotherapy in localised prostate cancer: protocol for a prospective cohort integrating MCTQ and salivary DLMO.

Clinical and translational radiation oncology·2026
Same author

Vision-zero: a roadmap for implementing metal screening devices to reduce preventable harm during MRI.

International journal of health care quality assurance·2026

Area of Science:

  • Oncology
  • Genetics
  • Virology

Background:

  • Human papillomaviruses (HPV) are critical in cervical cancer development.
  • Cervical cancer involves complex interactions between viral and cellular genes affecting cell-cycle control.
  • The TP73 gene, located on chromosome 1p36.3, is frequently lost in various human cancers.

Purpose of the Study:

  • To investigate the p73 cytosine thymine polymorphism and loss of heterozygosity (LOH) at the TP73 locus in cervical cancer.
  • To determine the association between TP73 genetic alterations and clinical factors in cervical cancer patients.

Main Methods:

  • Polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) was used.
  • Analysis included 134 DNA samples from 67 primary invasive cervical tumors and corresponding peripheral blood.

Related Experiment Videos

  • Genotyping and LOH analysis were performed on tumor and normal DNA samples.

    • Main Results:

    • Genotype frequencies were 56.7% for GC/GC and 43.3% for GC/AT.
    • The GC/AT genotype was associated with earlier age at menarche (P=0.039) and high parity (P=0.015).
    • Loss of the AT allele (LOH) was observed in 20.0% of tumor samples.
    • The AT allele was conserved in women with high parity but lost in 33.3% of patients with low parity (P=0.041).

    Conclusions:

    • TP73 genetic alterations, including LOH, may play a role in cervical cancer genesis and progression.
    • The findings suggest a link between TP73 alterations, pregnancy-related factors, and cervical carcinogenesis in HPV-infected individuals.
    • The study highlights the potential contribution of TP73 gene status to cervical cancer development, particularly under specific reproductive conditions.